Literature DB >> 3595608

Receptors for cholecystokinin and gastrin peptides display specific binding properties and are structurally different in guinea-pig and dog pancreas.

D Fourmy, A Zahidi, R Fabre, M Guidet, L Pradayrol, A Ribet.   

Abstract

In the light of the strong potency of gastrin-related peptides on pancreatic exocrine secretion in dog, we analyzed the binding properties of peptides related to cholecystokinin (CCK) and gastrin on dog pancreatic acini compared to guinea-pig acini. Moreover, we determined apparent molecular masses of photoaffinity labelled CCK/gastrin receptors in the two models. Using the CCK radioligand, receptor selectivity towards CCK/gastrin agonists and antagonists was found to be lower in dog acini than in guinea-pig acini. Performing the binding with CCK and gastrin radioligands in combination with N2,O2'-dibutyryl-guanosine 3',5'-monophosphate, revealed that in dog acini there exist two different sub-classes of CCK/gastrin receptors having high and low selectivity, the latter ones being able to bind gastrin with high affinity (Kd = 2.1 nM). SDS-PAGE analysis of covalently cross-linked receptors using several photosensitive CCK and gastrin probes of different peptide chain lengths demonstrated that in guinea-pig, CCK peptides bound to a 84-kDa component whereas in dog pancreas, CCK and gastrin peptides bound to three distinct molecular species (Mr approximately equal to 78,000, 45,000, 28,000). Performing cross-linking in the presence of 1 microM CCK indicated that a 45-kDa protein is the putative CCK/gastrin receptor in dog pancreas. Our results support the concept of heterogeneity of CCK/gastrin receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595608     DOI: 10.1111/j.1432-1033.1987.tb11495.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression.

Authors:  S A Wank; J R Pisegna; A de Weerth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  Characterization of gastrin binding to colonic mucosal membranes of guinea pigs.

Authors:  S Narayan; L Chicione; P Singh
Journal:  Mol Cell Biochem       Date:  1992-06-26       Impact factor: 3.396

3.  Role of AMP-18 in oral mucositis.

Authors:  Peili Chen; Mark Lingen; Stephen T Sonis; Margaret M Walsh-Reitz; F Gary Toback
Journal:  Oral Oncol       Date:  2011-07-06       Impact factor: 5.337

4.  Effect of chronic endogenous hypergastrinaemia on pancreatic growth and carcinogenesis in the hamster.

Authors:  M Chu; E Kullman; J F Rehfeld; K Borch
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

Review 5.  On the role of cholecystokinin in pancreatic cancer.

Authors:  M K Herrington; T E Adrian
Journal:  Int J Pancreatol       Date:  1995-04

6.  The effect of gastrin on growth of human stomach cancer cells.

Authors:  J Ishizuka; J Martinez; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1992-05       Impact factor: 12.969

7.  Expression cloning and characterization of the canine parietal cell gastrin receptor.

Authors:  A S Kopin; Y M Lee; E W McBride; L J Miller; M Lu; H Y Lin; L F Kolakowski; M Beinborn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

8.  Caerulein and gastrin(2-17 ds) regulate differently synthesis of secretory enzymes, mRNA levels and cell proliferation in pancreatic acinar cells (AR4-2J).

Authors:  P Pradel; A Estival; C Seva; C Wicker-Planquart; A Puigserver; N Vaysse; F Clemente
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

Review 9.  Distinguishing multiple CCK receptor subtypes. Studies with guinea pig chief cells and transfected human CCK receptors.

Authors:  R T Jensen; J M Qian; J T Lin; S A Mantey; J R Pisegna; S A Wank
Journal:  Ann N Y Acad Sci       Date:  1994-03-23       Impact factor: 5.691

10.  Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas.

Authors:  C Tang; I Biemond; G J Offerhaus; W Verspaget; C B Lamers
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.